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Correlation of adherence to the 2012 Infectious Diseases Society of 
America practice guidelines with patient outcomes in the treatment 
of diabetic foot infections in an outpatient parenteral antimicrobial 
programme 
Pence LM, Mock CM, Kays MB, Damer KM, Muloma EW, Erdman SM 
Abstract 
Aim 
To evaluate adherence to the 2012 Infectious Diseases Society of America practice guidelines for the 
management of patients with diabetic foot infections and to determine an association between adherence 
and clinical outcome. 
Methods 
A retrospective chart review was performed to evaluate the management and clinical outcomes of patients 
with diabetic foot infections treated with outpatient parenteral antimicrobial therapy between 1 January 
2011 and 30 June 2012 at Wishard Health Services/Eskenazi Health. Adherence to individual Infectious 
Diseases Society of America diabetic foot infection treatment guideline recommendations was measured, 
and then assessed in relation to clinical outcome. 
Results 
A total of 57 patients (61% male, mean age 54 years) with moderate to severe diabetic foot infection met 
the inclusion criteria. None of the treatment courses of these patients adhered to all the Infectious 
Diseases Society of America guideline recommendations. The recommendations most frequently adhered 
to were consultation of appropriate multidisciplinary teams (n=54, 94.7%) and performance of diagnostic 
imaging (n=52, 89.5%). The recommendations least frequently adhered to were diabetic foot wound 
classification scoring on admission (n=0, 0%), appropriate culture acquisition (n=12, 21.2%), surgical 
intervention when indicated (n=32, 46.2%) and appropriate empiric antibiotic selection (n=34, 59.7%). Of 
56 patients, 52 (92.9%) experienced clinical cure at the end of outpatient parenteral antimicrobial therapy 
compared with 34 of 53 patients (64%) at 6 months after the completion of therapy. Adherence to 
individual guidelines was not associated with clinical outcome. Patients who experienced treatment 
failure were more likely to have severe diabetic foot infection or peripheral neuropathy. 
Conclusions 
Adherence to the Infectious Diseases Society of America diabetic foot infection guideline 
recommendations was found to be suboptimal in the present study. The effect of adhering to individual 
Infectious Diseases Society of America diabetic foot infection recommendations on clinical outcome 
needs to be investigated. 
 
 
 
 
Introduction 
The multiple complications associated with diabetes mellitus are a continuing challenge for 
clinicians and lead to frequent hospitalizations, reduced quality of life and healthcare costs of 
$500 million annually [1]. Of these complications, diabetic foot infection is the most common 
reason for diabetes-related hospitalization and lower extremity amputation in patients with 
diabetes [2, 3]. Diabetic foot infections are notoriously difficult to treat, with reported failure rates 
of 30–40% [3-7] and up to 15% of patients requiring amputation [8]. To address these management 
issues, the Infectious Diseases Society of America (IDSA) released updated clinical practice 
guidelines in 2012 for the diagnosis and treatment of diabetic foot infections [2, 9]. 
Some patients with diabetic foot infection require treatment with parenteral antimicrobial therapy, 
which may be administered through the use of outpatient parenteral antimicrobial therapy (OPAT). 
The increased use of OPAT in recent years is attributable to the accumulating literature 
highlighting its safety and efficacy in patients with certain infection types, and the lower costs 
associated with this form of care [10, 11]. To date, there have been limited published data on the 
use of OPAT for the treatment of patients with diabetic foot infection. Studies have either evaluated 
OPAT in cohorts where diabetic foot infection comprised a subset of patients or have evaluated 
the use of a specific antibiotic regimen in the treatment of diabetic foot infection [11-13]. In 
addition, few studies have identified risk factors associated with treatment failure in diabetic foot 
infection [3, 5]. 
The aim of the present study was to evaluate clinician adherence to the individual 
recommendations within the updated 2012 IDSA diabetic foot infection clinical practice guidelines 
and to determine whether there was an association between guideline adherence and clinical 
outcome. In addition, we investigated the risk factors associated with diabetic foot infection 
treatment failure and the use of OPAT for the management of diabetic foot infection. 
Patients and methods 
Study design 
The present study was a retrospective, observational chart review performed at Wishard Health 
Services/Eskenazi Health, a 339-bed, university-affiliated, county teaching hospital in 
Indianapolis, Indiana. Wishard Health Services/Eskenazi Health has a formal OPAT programme, 
whereby, according to a hospital quality mandate, the inpatient Infectious Diseases consultation 
service must review and approve the use of OPAT before the patient is discharged from the 
hospital. The electronic medical records and OPAT clinic charts of adult patients admitted with 
diabetic foot infection with or without osteomyelitis and subsequently discharged to the Wishard 
Health Services/Eskenazi Health OPAT programme between 1 January 2011 and 30 June 2012 
were retrospectively reviewed by study personnel. Children, pregnant women and prisoners were 
excluded from the analysis, as were patients with orthopaedic hardware-related infection or stump 
infection. 
The data collected for each patient, when available, included: (1) demographic/patient information: 
age, gender, ethnicity, BMI, smoking status, recent HbA1c level, previous diabetic foot 
infection/amputation and comorbidities including peripheral arterial disease, chronic kidney 
disease or peripheral neuropathy; (2) diabetic foot infection and treatment information: duration 
of ulcer prior to admission, diabetic foot wound classification on admission, antibiotics used, 
recommendations for surgery as determined by medical/surgical services, site of OPAT, duration 
of therapy, compliance with prescribed OPAT regimen, compliance with OPAT clinic 
appointments; (3) compliance with IDSA guideline recommendations, which were condensed into 
11 specific and measurable recommendations summarized in Table 1 [2, 9, 14, 15]; and (4) clinical 
outcome at completion of OPAT and 6 months after completion of OPAT. The clinical outcome 
data at each time point was categorized as either treatment success, which was defined as resolution 
of all signs and symptoms of infection without re-infection of the original ulcer, or treatment 
failure, which was defined as lack of resolution of one of the original signs and symptoms of 
infection or re-infection of the original ulcer leading to re-hospitalization, amputation or surgery 
during OPAT or < 6 months after OPAT completion. For patients without diabetic foot wound 
classification scoring on admission, a PEDIS grade [15] was calculated retrospectively to classify 
the severity of the diabetic foot infection. For patients who received multiple OPAT courses for 
diabetic foot infection during the study period, only the first diabetic foot infection episode was 
included. 
The primary outcome measure was the number of patients with diabetic foot infection managed in 
accordance with each of the individual recommendations of the 2012 IDSA diabetic foot infection 
treatment guidelines. In addition, patient compliance to the recommended OPAT course was 
assessed and defined as documentation of patient willingness to comply with 90% of OPAT doses 
(which was confirmed during each OPAT clinic visit) as well as documented attendance at all 
OPAT clinic appointments. Secondary outcome measures were treatment success or failure at the 
end of OPAT therapy and at 6 months after OPAT completion, changes in glucose control at 
6 months, and risk factors associated with treatment failure. 
Using descriptive statistics, the data during the patient's inpatient stay, OPAT treatment, and for 
up to 6 months after the completion of OPAT were analysed. Chi-squared and unpaired t-tests 
were performed, as appropriate, to compare the treatment success and treatment failure groups at 
the completion of OPAT therapy and at 6 months after the completion of OPAT, as well as to 
determine the risk factors associated with treatment failure. A P value of ≤ 0.05 was considered 
statistically significant. 
The study was approved by the Indiana University institutional review board. 
Results 
During the study period, 326 patients received OPAT for the treatment of infection, with 73 of 
these patients (22.4%) receiving OPAT for the treatment of diabetic foot infection, with or without 
osteomyelitis. Of the 73 patients who received OPAT for diabetic foot infection, 57 (78.1%) met 
the inclusion criteria. Sixteen patients (21.9%) were excluded from the analysis due to 
incarceration (n = 7), receipt of the entire antimicrobial course as an inpatient (n = 5), or the 
presence of stump or orthopaedic hardware-related infections (n=4). 
Table 1. Summary of Infectious Diseases Society of America diabetic foot infection guidelne recommendations [2] 
Recommendation Description 
Diabetic foot wound 
classification scoring performed 
at baseline 
Wound classified using one recommended diabetic foot wound classification method (PEDIS 
Grade [15], IDSA wound classification [9], University of Texas [14]) to classify wound as 
mild, moderate or severe 
Appropriate imaging techniques 
performed 
Plain radiograph +/- MRI or white blood cell scan performed if osteomyelitis suspected OR 
MRI only 
Assessment of arterial 
ischaemia performed Ankle brachial index performed and documented in patient chart 
Consultation of appropriate 
multidisciplinary teamsa 
Two or more of the following specialty teams consulted: Infectious Diseases, Orthopaedics, 
Vascular Surgery, Wound Care/Physical Therapy 
Appropriate surgical procedures 
performed, when indicated 
Incision and drainage performed +/- amputation or resection as indicated in patients with 
vascular insufficiency, extensive damage, etc.  
Cultures obtained appropriately 
Tissue obtained for culture via either curettage or incision and drainage (not superficial 
swabs), or bone biopsy for patients with suspected osteomyelitis; cultures obtained before 
initiating antibiotics 
Appropriate empiric antibiotic 
regimen selected based on 
initial diabetic foot wound 
classification and risk factor 
assessment 
Empiric antibiotic regimen appropriate based on severity of infection and only provides 
coverage against Pseudomonas aeruginosab or MRSAc in patients at risk of infection due to 
these organisms.  
Appropriate targeted antibiotic 
regimen selected based on 
culture results 
Antibiotic therapy appropriately de-escalated based on culture results. If no cultures were 
obtained, continued therapy should provide coverage against Pseudomonas aeruginosab and 
MRSAc only in patients at risk of infection due to these organisms.  
Wound care recommendations 
provided to patient 
Wound care recommendations should be clearly explained to patient and documented in 
patient chart. 
Offloading recommendations 
provided to patient 
Offloading recommendations should be clearly explained to patient and documented in 
patient chart 
Appropriate duration of 
antibiotic therapy received 
based on infection type 
Patient received the recommended duration of antibiotic therapy based on diagnosis and 
treatment course: 1–2 weeks for mild infection, 1–3 weeks for moderate infection, 2–4 weeks 
for severe infection, 6 weeks for osteomyelitis, 2–5 days for amputation/resection of 
osteomyelitis with clean margins 
IDSA, Infectious Diseases Society of America; MRI, magnetic resonance imaging, MRSA, methicillin-resistant 
Staphylococcus aureus 
 aExcluding podiatry since inpatient podiatric services are not available at our institution. 
 bOnly in patients with a history of soaking wound or in patients with severe infection upon presentation. 
cOnly in patients with a history of MRSA within the preceding year or in patients with severe infection upon presentation. 
 
 
The baseline characteristics of evaluable study patients are summarized in Table 2. The majority 
of patients were male (n = 35, 61%) with a mean (range) age of 54 (29–84) years. The mean (range) 
weight of study patients was 95 (54.6–212) kg and mean (range) BMI was 31.7 (19–63.4) kg/m2. 
Forty-four percent of patients (n = 25) had pre-existing peripheral neuropathy, and the mean 
(range) HbA1c concentration on admission was 77 (37–160) mmol/mol or 9.2 (5.5–16.8)%. In all, 
63% of patients had a history of previous diabetic foot infection (n = 36), with 37% (n = 21) having 
previously undergone amputation as a result of diabetic foot infection. 
Table 2. Baseline patient/demographic characteristics (N =57) 
Male gender, n (%) 35 (61.4) 
Ethnicity, n (%) 
    White 24 (42.1) 
    Black 28 (49.1) 
    Hispanic 5 (8.7) 
Cigarette smoker, n (%) 16 (28.1) 
Comorbidities, n (%) 
    Peripheral arterial disease 13 (22.8) 
    Neuropathy 25 (43.8) 
    Chronic kidney disease 15 (26.3) 
Age, years 
    Mean ± sd 54 ± 12 
    Range  29–84 
BMI, kg/m2 
    Mean ± sd 31.7 ± 7.9 
    Range  19–63.4 
HbA1c, mmol/mol 
    Mean ± sd 77± 27 
    Range 37–160  
HbA1c,% 
    Mean ± sd 9.2 ± 2.5 
Range 5.5–16.8 
 
None of the patients underwent diabetic foot wound classification on admission, so this was 
performed retrospectively during chart review. All diabetic foot infections were classified as 
moderate (n = 39, 68.4%) or severe (n = 18, 31.5%) on admission (PEDIS Grade 3 or 4), as shown 
in Table 3 [2, 15]. The majority of patients received OPAT at home (n = 31, 54%), while 44% (n 
= 25) received OPAT at a rehabilitation or long-term care facility and 2% (n = 1) received OPAT 
during haemodialysis. 
Adherence to guidelines 
Overall, none of the diagnostic and treatment regimens of the 57 patients with diabetic foot 
infection incorporated all 11 recommendations from the IDSA diabetic foot infection guidelines. 
Table 4 shows the adherence to the individual diabetic foot infection guideline recommendations, 
including adherence to the guidelines based on clinical outcome. The recommendations most 
commonly adhered to were: consultation of appropriate multidisciplinary teams (infectious 
diseases, orthopedics, vascular surgery, and/or wound care; n = 54, 94.7%); performance of proper 
diagnostic imaging (n = 52, 89.5%); appropriate duration of antibiotic therapy (n = 51, 89.5%); 
and documentation of wound care recommendations (n = 48, 84.5%). The recommendations least 
frequently adhered to were: diabetic foot wound classification scoring on admission (n = 0, 0%); 
appropriate culture technique (n = 12, 21%); incision and drainage and/or amputation performed 
when indicated (n = 32, 56%); and appropriate empiric antibiotic selection (n = 34, 59.7%). Of the 
45 patients (79%) whose cultures were not obtained appropriately, superficial wound cultures were 
performed in 21 patients (46.7%), cultures were obtained after the initiation of antibiotic therapy 
in five patients (11.1%), and cultures were not obtained in 19 patients (42.2%). Diagnostic bone 
biopsy was performed in only six of 49 (12%) patients with osteomyelitis in this study. Overall, 
there were 12 different antibiotic regimens used during empiric therapy, with a combination of 
vancomycin and piperacillin/tazobactam being used most frequently (n = 43, 75.4%). A total of 
23 patients (40.4%) received inappropriate empiric antibiotic therapy on admission. All of these 
patients were classified as having moderate diabetic foot infection on admission, with 16 patients 
(28.1%) receiving inappropriate empiric therapy that provided coverage against methicillin-
resistant Staphylococcus aureus and seven patients (12.3%) receiving inappropriate empiric 
therapy that provided antipseudomonal coverage in the absence of risk factors for these organisms. 
All empiric and targeted antibiotic regimens provided coverage against the bacteria that were 
isolated by culture, regardless of the appropriateness of the culture acquisition technique. For the 
12 patients with adequate culture specimens, broad spectrum empiric antibiotic regimens were 
appropriately de-escalated in only seven patients (58%). 
Treatment outcome 
The majority of patients (n= 52/56, 92.9%) experienced treatment success upon completion of 
OPAT. One patient did not return for OPAT clinic follow-up after hospital discharge, and three 
additional patients were lost to follow-up at 6 months after completion of OPAT. Of the 53 patients 
with follow-up at 6 months, 34 patients (64%) experienced resolution of infection, while 19 
patients (36%) experienced treatment failure requiring hospitalization/retreatment (n = 11) or 
amputation (n = 8). Patients with treatment failure were more likely to have received appropriate 
empiric (74 vs 47%, respectively) and targeted (84 vs 68%, respectively) antibiotic therapy than 
patients with treatment success. The mean HbA1c level decreased from 77 mmol/mol or 9.2% on 
admission to a mean (range) of 65 (32–124) mmol/mol or 8.1 (5.1–13.5)% 6 months after the 
completion of OPAT. 
Risk factors for treatment failure 
The presence of severe diabetic foot infection on admission and peripheral neuropathy were 
significantly associated with treatment failure (Table 4). Nine of 19 patients (47.3%) with 
treatment failure had severe diabetic foot infection classification at baseline compared with seven 
of 34 patients (20.6%) with treatment success (P=0.04). Nine of 19 patients (47.3%) with treatment 
failure had peripheral neuropathy at baseline compared with six of 34 patients (17.6%) with 
treatment success (P=0.02). Non-adherence to any specific individual IDSA guideline 
recommendation was not found to be a significant risk factor for treatment failure. Multivariate 
analysis did not demonstrate any combination of variables that were significantly associated with 
clinical outcome. 
Discussion 
Diabetic foot infections are notoriously difficult to treat and contribute to significant morbidity in 
patients with diabetes. This is often attributable to the presence of neuropathy, vascular disease 
and impaired immunity, which all increase the risk of infection and contribute to the severity of 
infection, especially in patients with uncontrolled diabetes [2, 16, 17]; therefore, successful 
treatment of diabetic foot infection requires a multidisciplinary approach to optimize clinical 
outcomes, as outlined and emphasized in the recent 2012 IDSA diabetic foot infection clinical 
practice guidelines. This rigorous and comprehensive approach to diabetic foot infection must 
extend throughout the course of a patient's treatment to achieve successful clinical outcomes. 
In the present study, none of the treatment courses of the 57 patients with diabetic foot infection 
complied with all 11 IDSA diabetic foot infection guideline recommendations. The lack of 
adherence to specific diabetic foot infection guideline recommendations may have had a direct 
impact on the treatment and subsequent clinical outcomes of these patients. For example, many 
patients were started on empiric antibiotic therapy that was too broad, based on diabetic foot wound 
classification and risk factors for methicillin-resistant S. aureus or Pseudomonas aeruginosa. The 
inappropriate use of empiric antibiotic therapy was primarily attributed to lack of diabetic foot 
wound classification on admission, which is the main parameter used to guide empiric antibiotic 
therapy. In all patients, empiric antibiotic therapy provided coverage against bacteria that were 
eventually isolated in culture (whether or not the culture was obtained appropriately); however, 
the initial antibiotic choice was often too broad, which may contribute to antibiotic resistance and 
unwanted toxicities. There is a vital need for improvement in using diabetic foot wound 
classification scoring techniques to classify diabetic foot infection at baseline. The present study 
did not clarify why diabetic foot wound classification scoring was not performed, but one 
hypothesis is that the new clinical practice guidelines were released during the study period so that 
clinicians were not yet familiar with the importance of diabetic foot wound classification and 
assessment of risk factors for Pseudomonas aeruginosa and methicillin-resistant S. aureus on 
empiric therapy selection. It is also possible that clinicians who started empiric antibiotic therapy 
were waiting for the wound care team to fully assess and classify the wound, and were unaware 
that their baseline diabetic foot wound classification should influence the choice of antibiotic 
therapy. 
In the present study, the appropriate acquisition of cultures was performed in only 12 patients 
(21%). It is somewhat discouraging that antibiotic therapy was not appropriately de-escalated in 
42% of these patients, and is an area of improvement currently being targeted by our inpatient 
infectious disease consultation team. In the 45 patients (79%) whose cultures were not obtained 
appropriately, 21 (47%) patients had surface swabs of their wound submitted for culture that 
probably led to directed antibiotic therapy with too broad a coverage because regimens were 
chosen to provide activity against colonizing bacteria not directly causing the diabetic foot 
infection; 19 patients (45%) did not have any cultures submitted, prompting clinicians to use 
empiric antibiotic regimens without definitive culture data that may lead to therapy that is too 
broad or provides inadequate coverage; and five patients (11%) had cultures performed after the 
initiation of antibiotic therapy. After analysing the data, however, all empiric and targeted 
antibiotic regimens provided coverage against the organisms that were isolated in culture. 
Only 60.8% of patients underwent assessment for arterial ischaemia using the ankle brachial index 
measurement, which may have contributed to suboptimal treatment response in some patients who 
received only antibiotic therapy when revascularization or amputation was also needed because of 
underlying vascular insufficiency. Lastly, source control procedures (incision and drainage, 
amputation/resection as indicated) were not performed in 43.8% of patients, including 13 patients 
in whom amputation was recommended but not performed because of patient refusal (n = 11) or 
poor candidacy for surgery (n = 2). These low rates of surgical intervention probably contributed 
to treatment failure in some patients. 
The clinical outcomes in the present study are consistent with those reported in other diabetic foot 
infection treatment studies [3-7, 13]. It is interesting to note that patients with treatment failure 
received more appropriate empiric and directed antibiotic therapy when compared with patients 
with treatment success. When analysing the details of these 19 patients, 14 (74%) presented with 
diabetic foot infection and associated osteomyelitis, and three did not receive recommended 
surgical intervention because of patient refusal (n = 2) and comorbidities (n = 1). It is unlikely that 
antibiotic therapy alone would have eradicated infection in the patients with treatment failure, and 
the poor clinical outcome observed in these patients is probably attributable to the severity of 
infection on presentation and lack of surgical intervention/source control. 
The risk factors significantly associated with treatment failure in the present study were severe 
wound classification on admission and the presence of peripheral neuropathy. The risk factors 
associated with treatment failure in other diabetic foot infection studies include severe diabetic 
foot wound classification at baseline and leukocytosis [3]; and fever on admission, elevated serum 
creatinine levels, previous hospitalization for diabetic foot infection, the presence of gangrene or 
peripheral vascular disease, and severe diabetic foot wound classification [5]. The presence of 
peripheral neuropathy as a predictor of treatment failure in the present study differs slightly from 
existing literature [3, 5]. Neuropathy is probably an indicator for treatment failure as persistent 
hyperglycaemia and uncontrolled diabetes foster the development of neuropathy, which can also 
lead to immunopathy and defects in leukocyte function [16-18]. 
The present study was unique in that it was conducted in a patient population receiving OPAT. 
After discharge, patients were closely managed with weekly laboratory tests and periodic follow-
up clinic visits to assess infection status and antimicrobial treatment. The close monitoring and 
frequent visits required by the OPAT programme were important for this study, as patients were 
assessed throughout their entire treatment course for clinical outcome. Institution of an OPAT 
programme in hospital systems that do not currently have this service would provide close patient 
evaluation throughout the treatment process, and could quickly link patients to appropriate care if 
treatment was not progressing appropriately. This could potentially improve patient outcome and 
decrease the overall healthcare costs associated with the management of diabetic foot infection, 
although this study did not specifically assess this outcome. 
The present study has several limitations. Firstly, it was a retrospective chart review. Because none 
of the patients underwent diabetic foot wound classification on admission, all wounds were 
retrospectively classified using data in the patient's medical chart to determine the appropriateness 
of empiric antimicrobial therapy. This retrospective diabetic foot wound classification may have 
led to misclassification as it was based on documentation of variables used for scoring (e.g. vital 
signs, size of surrounding erythema, etc.). Secondly, the sample size was relatively small, which 
probably led to an inability to detect significant differences between treatment success and failure 
groups with regard to adherence to specific guideline recommendations and risk factors for 
treatment failure. Thirdly, the 2012 IDSA clinical practice guidelines for the diagnosis and 
treatment of diabetic foot infection were published during the study period. While the general 
management recommendations in the 2004 IDSA diabetic foot infection guidelines were similar 
to those in the newer guidelines, the 2012 guidelines provided more specific information on 
diabetic foot wound classification, wound care techniques and offloading, and more thorough 
analysis of appropriate antibiotic regimens. The introduction of the 2012 IDSA diabetic foot 
infection guidelines may therefore have led to a heightened awareness of the need for specific 
treatment methods in this patient population. Lastly, since this study was performed at a single, 
county teaching hospital, the results may not be applicable to all patients with diabetic foot 
infection. 
The present study re-emphasizes the overall complexity of diabetic foot infection management, 
which often involves many healthcare disciplines for optimal patient outcomes. More studies are 
needed to assess the appropriateness of diabetic foot infection management, with inclusion of a 
broader scope of hospital systems, to identify specific risk factors and management 
recommendations that contribute to improved clinical outcomes in this patient population. Since 
treatment outcomes in this patient population are notoriously poor, greater attention to the 
individual recommendations in the IDSA diabetic foot infection clinical practice guidelines for 
each patient may lead to better patient outcomes and, therefore, warrants further study. The results 
of our study have prompted an institution-wide initiative to provide more comprehensive and 
consistent diagnostic and treatment approaches to patients with diabetic foot infection. 
 
 Table 3. Diabetic foot infection an teatment information (N = 57) 
Diabetic foot wound classification EDIS grade, n (%)   
Moderate 39 (68.4) 
Severe 18 (31.5) 
Diagnosisa, n (%) 
Osteomyelitis 49 (85.9) 
Cellulitis 24 (42.1) 
Abscess 10 (17.5) 
Septic Arthritis 8 (14) 
Gangrene 6 (10.5) 
Otherb 4 (7) 
Empiric antibiotic therapy regimens, n (%) 
Vancomycin + piperacillin/tazobactam 43 (75.4) 
Vancomycin + cefepime 2 (3.5) 
Vancomycin + meropenem 3 (5.2) 
Otherc 9 (15.7) 
OPAT site, n (%) 
Home 31 (54.3) 
Rehabilitation/long-term care facility 25 (43.8) 
Dialysis clinic 1 (1.7) 
Clinical outcome after completion of OPAT (N = 56), n (%) 
Resolution of infection 52 (92.9) 
Continued signs of infection 4 (7.1) 
Clinical outcome 6 months after completion of OPAT (N = 53), n (%) 
Success 34 (64.2) 
Failure 19 (35.8) 
Duration of ulcer prior to admission, days 
Mean ± sd 35 ± 62 
Range 1–365 
Duration of antimicrobial therapy, days 
Mean 51 ± 21 
Range 14–116 
OPAT, outpatient parenteral antimicrobial therapy; LTCF, long-term care facility. 
a Some patients had more than one diagnosis on presentation. 
b Includes tenosynovitis (n = 2), Charcot arthropathy (n = 1), and myositis (n = 1). 
c Includes vancomycin+clindamycin+cefepime, vancomycin+imipenem, ciprofloxacin+clindamycin, meropenem, vancomycin+meropenem+clindamycin, 
vancomycin+clindamycin, daptomycin+meropenem, vancomycin+piperacillin/tazobactam+clindamycin, and vancomycin+ciprofloxacin 
Table 4. Adherence to Infectious Diseases Society of America diabetic foot infection guidelines, recommended outpatient parenteral 
antimicrobial therapy course and risk factors for treatment success or failure 
  Overall adherence (n 
= 57) 
Successa 
(n=34) 
Failurea 
(n=19) 
P  
Recommendation  
Diabetic foot wound classification performed, n (%) 0 (0) 0 (0) 0 (0) — 
Proper diagnostic imaging performed, n (%) 53 (91,2) 32 (92.4) 16 (84.2) 0.24 
Assessment of arterial ischaemia performed, n (%) 35 (60.8) 20 (58.8) 11 (57.8) 0.95 
Consultation of appropriate multidisciplinary teams, n (%) 54 (94.7) 31 (91.2) 19 (100) 0.18 
Appropriate surgical procedures performed, when indicated, n (%) 32 (56.2) 21 (61.8) 11 (57.9) 0.78 
Cultures obtained appropriately, n (%) 12 (21.1) 7 (20.6) 5 (26.4) 0.63 
Appropriate empiric antibiotic regimen selected, n (%) 34 (59.7) 16 (47.1) 14 (73.7) 0.06 
Appropriate targeted antibiotic regimen selected, n (%) 42 (73.7) 23 (67.6) 16 (84.2) 0.19 
Wound care recommendations provided to patient, n (%) 48 (84.9) 28 (82.4) 17 (89.5) 0.49 
Offloading recommendations provided to patient, n (%) 36 (62.5) 24 (70.6) 10 (52.9) 0.19 
Appropriate duration of antibiotic therapy received based on infection 
   
51 (89.5) 33 (97.1) 18 (94.7) 0.67 
Patient compliance with OPAT course, n (%) 41 (71.5) 28 (82.3) 13 (68.5) 0.25 
Risk factor  
Mean age, years — 54 51 0.31 
Mean BMI, kg/m2 — 32 31.8 0.51 
Mean baseline HbA1c —       
mmol/mol   74 79 0.96 
%   8.9 9.4   
Cigarette smoker, n (%) — 10 (29.4) 5 (26.3) 0.81 
Previous diabetic foot infection, n (%) — 18 (52.9) 14 (73.6) 0.14 
Previous amputation, n (%) — 10 (29.4) 8 (42.1) 0.35 
Peripheral arterial disease, n (%) — 14 (41.1) 4 (21) 0.14 
Peripheral neuropathy, n (%) — 6 (17.6) 9 (47.3) 0.02 
Chronic kidney disease, n (%) — 8 (23.5) 6 (31.5) 0.52 
Moderate diabetic foot infection on admission, n (%) — 27 (79.4) 10 (52.6) 0.04 
Severe diabetic foot infection on admission, n (%) — 7 (20.6%) 9 (47.3%) 0.04 
OPAT, outpatient parenteral antimicrobial therapy. 
aAssessed 6 months after the completion of OPAT. 
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